Knee Replacement Revision Risk May Be Higher In Smokers: Study

Research suggests that smoking may be a notable factor in the risk of early knee implant failure, coming at a time when a number of knee implant systems sold in recent years are under increased scrutiny for high rates problems. 

The study was published in the October issue of the medical journal The Knee, indicating that current smokers faced higher rates of revision surgery than non-smokers or even former-smokers. Researchers also found that the length of time before a knee replacement revision was needed was shorter for smokers than non-smokers or ex-smokers.

Stanford University researchers looked at 619 revision procedures involving total knee arthroplasty (TKA) referred to one academic tertiary center, looking at smoking status compared to time to revision and other factors.

According to the findings, smokers had an increased risk of early knee revision surgery for any reason, compared to both non-smokers and ex-smokers. Previous studies have also linked smoking to an increased risk of early postoperative complications, increased hospital stays and an overall increased risk of revision surgery.

“Smoking appears to have an all-or-none effect on earlier revision TKA as patients who smoked more did not have higher risk of early revision TKA,” the researchers noted. “These results highlight the need for clinicians to urge patients not to begin smoking and encourage smokers to quit smoking prior to primary TKA.”

The study did not look at reasons why smoking may cause knee implant failures at a higher rate, but comes as a number of knee implants face claims of high failure rates, particularly due to tibial plate failures.

The complaints have led to a growing number of knee replacement lawsuits filed in recent months over problems associated with several different types of systems widely used in recent years.

Similar allegations involving tibial failures have also been cited in recent DePuy Attune Knee lawsuits, as well as complaints over the Exactech Optetrak Total Knee Replacement System, and the Arthrex iBalance knee system.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer.
Roblox is facing a lawsuit from a Georgia mother who alleges the platform’s failure to implement adequate child safety measures allowed online predators to groom her young son.